The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between Mpro and antiviral drugs (nirmatrelvir and ritonavir)
Ali Adel Dawood
Topics & Concepts
RitonavirDocking (animal)MedicineCoronavirus disease 2019 (COVID-19)PharmacologyCoronavirusProteaseVirologyDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computational biologyVirusInfectious disease (medical specialty)ChemistryDiseaseBiologyViral loadEnzymeInternal medicineBiochemistryAntiretroviral therapyNursingSARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsPARP inhibition in cancer therapy